Literature DB >> 28818914

Complete Genome Sequence of Citrobacter freundii 705SK3, an OXA-48-Encoding Wastewater Isolate.

Katrin Zurfluh1, Roger Stephan2, Jochen Klumpp3, Magdalena Nüesch-Inderbinen2, Jörg Hummerjohann4, Claudia Bagutti5, Roger Marti2.   

Abstract

We present the genome sequence of Citrobacter freundii 705SK3, a wastewater isolate harboring an IncL OXA-48-encoding plasmid. Assembly of the genome resulted in a 5,242,839-bp circular chromosome (GC content, 52%) and two closed plasmids of 296,175 bp and 63, 458 bp in size.
Copyright © 2017 Zurfluh et al.

Entities:  

Year:  2017        PMID: 28818914      PMCID: PMC5604787          DOI: 10.1128/genomeA.00842-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Citrobacter freundii is an opportunistic pathogen and is frequently found in the environment (water and soil), but it has also been isolated from food and the intestines of animals and humans. Although its virulence potential is rather low, C. freundii can be the causative agent of a wide spectrum of infections involving the gastrointestinal, urinary, or respiratory tract or even the central nervous system (1). C. freundii possesses an inducible AmpC β-lactamase, which can pose a challenge for antibiotic susceptibility reporting because an in vitro susceptibility may not correlate with clinical efficacy (2). With the general increase in the number of carbapenemase-producing Enterobacteriaceae, reports of carbapenemase-producing C. freundii have also increased (3–6). The main carbapenemases produced by Enterobacteriaceae belong to the Ambler class A (e.g., KPC), class B (e.g., IMP, VIM, and NDM) or class D (e.g., OXA-48 and its variants). Class D β-lactamases generally possess weak but significant carbapenemase activity (7). However, the combination of an (inducible) AmpC β-lactamase together with an OXA-48 makes such isolates resistant against almost all β-lactams available. Here, we present the genome sequence of an OXA-48-producing C. freundii isolate collected from wastewater near Basel, Switzerland, in December 2015 (8). The genome was sequenced at the Functional Genomics Center Zurich (FGCZ) using Pacific Biosciences (PacBio) single-molecule real-time (SMRT) technology RS2 reads (C4/P6 chemistry). De novo assembly was performed using SMRTAnalysis 2.3 with the HGAP3 protocol. Annotation was done using the NCBI Prokaryotic Genome Annotation Pipeline (9). The MLST-1.8 server (10), ResFinder 2.1 (11), and PlasmidFinder 1.3 (12) were used to identify sequence type (ST), acquired resistance genes, and plasmid incompatibility types. The assembly resulted in one chromosome and two plasmids (all sequences were closed). The chromosome is 5,242,839 bp in size (GC content, 52%) and encodes the AmpC β-lactamase CMY-75. The isolate could not be assigned to an existing ST, although it is highly similar to ST112 (only one point mutation in the fadD gene: allele 69 position 363G → A). The larger of the two plasmids, p705SK3_1, is 296,175 bp in size with a GC content of 47.8% and does not contain any antimicrobial resistance genes. PlasmidFinder was not able to assign this plasmid to any plasmid incompatibility group. The second plasmid (63,458 bp, 51.2% GC content), p705SK3_2, belongs to the incompatibility type IncL and carries the blaOXA-48 gene. It shows remarkable similarities to the prototype of the IncL plasmids involved in the worldwide spread of OXA-48 (7, 13). The main difference was the presence of two IS1R elements on p705SK3_2 compared to pOXA-48 (GenBank accession number JN626286). The first IS1R is located 163 bp downstream of the blaOXA-48 gene, and the second is 380 bp downstream of korC, which encodes a hypothetical transcriptional repressor. Furthermore, p705SK3_2 possesses 99.96% identity to p704SK10_2 (CP022150), an OXA-48-encoding IncL plasmid extracted from an Enterobacter cloacae isolate from the same wastewater (14). The isolate C. freundii 705SK3 provides further proof that Citrobacter species are a potential reservoir for the widely disseminated OXA-48-encoding IncL plasmids.

Accession number(s).

Sequence and annotation data of the genome have been deposited in GenBank under accession numbers CP022151 (chromosome), CP022152 (p705SK3_1), and CP022153 (p705SK3_2). This is the first version of this genome.
  14 in total

1.  Multilocus sequence typing of total-genome-sequenced bacteria.

Authors:  Mette V Larsen; Salvatore Cosentino; Simon Rasmussen; Carsten Friis; Henrik Hasman; Rasmus Lykke Marvig; Lars Jelsbak; Thomas Sicheritz-Pontén; David W Ussery; Frank M Aarestrup; Ole Lund
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Spread of OXA-48-encoding plasmid in Turkey and beyond.

Authors:  Amélie Carrër; Laurent Poirel; Mesut Yilmaz; Ozay Arikan Akan; Cilli Feriha; Gaëlle Cuzon; Ghassan Matar; Patrick Honderlick; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

3.  Wastewater is a reservoir for clinically relevant carbapenemase- and 16s rRNA methylase-producing Enterobacteriaceae.

Authors:  Katrin Zurfluh; Claudia Bagutti; Peter Brodmann; Monica Alt; Jürg Schulze; Séamus Fanning; Roger Stephan; Magdalena Nüesch-Inderbinen
Journal:  Int J Antimicrob Agents       Date:  2017-06-28       Impact factor: 5.283

4.  Circulation of blaKPC-3-Carrying IncX3 Plasmids among Citrobacter freundii Isolates in an Italian Hospital.

Authors:  Carolina Venditti; Daniela Fortini; Laura Villa; Antonella Vulcano; Silvia D'Arezzo; Alessandro Capone; Nicola Petrosillo; Carla Nisii; Alessandra Carattoli; Antonino Di Caro
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  Emergence of a multidrug-resistant Citrobacter freundii ST8 harboring an unusual VIM-4 gene cassette in Poland.

Authors:  Piotr Majewski; Piotr Wieczorek; Izabela Łapuć; Dominika Ojdana; Anna Sieńko; Paweł Sacha; Janusz Kłoczko; Elżbieta Tryniszewska
Journal:  Int J Infect Dis       Date:  2017-06-27       Impact factor: 3.623

Review 6.  OXA-48-like carbapenemases: the phantom menace.

Authors:  Laurent Poirel; Anaïs Potron; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-04-11       Impact factor: 5.790

7.  In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.

Authors:  Alessandra Carattoli; Ea Zankari; Aurora García-Fernández; Mette Voldby Larsen; Ole Lund; Laura Villa; Frank Møller Aarestrup; Henrik Hasman
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

8.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

9.  Complete Genome Sequence of Enterobacter cloacae 704SK10, an OXA-48-Encoding Wastewater Isolate.

Authors:  Roger Marti; Roger Stephan; Jochen Klumpp; Magdalena Nüesch-Inderbinen; Jörg Hummerjohann; Claudia Bagutti; Katrin Zurfluh
Journal:  Genome Announc       Date:  2017-08-17

10.  Citrobacter freundii carrying blaKPC-2 and blaNDM-1: characterization by whole genome sequencing.

Authors:  Wenjing Wu; Björn Espedido; Yu Feng; Zhiyong Zong
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

View more
  2 in total

1.  Citrobacter telavivum sp. nov. with chromosomal mcr-9 from hospitalized patients.

Authors:  Teresa Gonçalves Ribeiro; Radosław Izdebski; Paweł Urbanowicz; Yehuda Carmeli; Marek Gniadkowski; Luísa Peixe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-08-17       Impact factor: 3.267

2.  Genomic, Morphological and Functional Characterization of Virulent Bacteriophage IME-JL8 Targeting Citrobacter freundii.

Authors:  Kaixiang Jia; Nuo Yang; Xiuwen Zhang; Ruopeng Cai; Yang Zhang; Jiaxin Tian; Sayed Haidar Abbas Raza; Yuanhuan Kang; Aidong Qian; Ying Li; Wuwen Sun; Jinyu Shen; Jiayun Yao; Xiaofeng Shan; Lei Zhang; Guiqin Wang
Journal:  Front Microbiol       Date:  2020-11-19       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.